Why This $18 Million Sale Might Signal a Shift as a China Tech Bet Falls 34%

RWC Asset Advisors sold 834,689 shares of Kanzhun Limited in Q4 2025 (estimated $18.03M based on quarter-average pricing), cutting its position to 1,509,151 shares valued at $30.76M and reducing Kanzhun to 5.83% of reported 13F AUM (from 8.96%). The quarter-end position value declined by $24.00M (reflecting sales plus price movement); Kanzhun shares traded at $13.63 as of Friday and are down 34% over the past year despite positive reported TTM revenue (~$1.16–$1.18B) and net income (~$360–$385M). The trade appears driven by risk-management and portfolio concentration (large commodity/EM positions) rather than company fundamentals, so market impact is limited to company-level flows rather than sector- or market-wide moves.

Analysis

RWC's trim is best read as portfolio-level de-risking rather than a pure fundamental downgrade: when a multi-strategy manager runs concentrated cyclicals and EM commodity bets, marginal reductions in smaller, idiosyncratic China tech names are the easiest lever to cut headline beta. That mechanical reweighting increases short-term supply into an already sentiment-sensitive register, so price action will likely be driven more by flow liquidity than by next-quarter metrics for several months.

Second-order winners are liquidity providers and listed derivatives on the stock — widening intraday spreads and higher options implied vols create a profitable environment for market-makers and volatility sellers; conversely, index-tracking vehicles with rebalancing rules could exacerbate swings. A true reversal will need an exogenous sentiment catalyst (regulatory calm, capital flow normalization, or a macro data point that materially improves Chinese hiring) rather than incremental company beats alone.

Tail risks skew toward geopolitics and sector-wide repricing: a renewed cross-border regulatory scare or a weakening Chinese labor market would compress multiples quickly, while an easing of those two would probably restore multiple expansion faster than earnings reacceleration. Time horizons matter — expect amplified moves over days-to-weeks from rebalancing, meaningful recovery paths over 6–12 months if sentiment normalizes, and secular upside over years only if platform monetization sustainably outpaces competition and ad-market cyclicality.

Key Decisions for Investors

• Small, asymmetric long via options: Buy BZ 9–12 month LEAPS (size 1–2% NAV). Target scenario: +40–60% if China sentiment normalizes; pain scenario: limit loss to 30% of notional by exiting on a 25% adverse move or 30-day realized vol spike above 70%.
• Pair trade to isolate idiosyncratic recovery: Long BZ cash (1–2% NAV) funded by a small short position in a broad China-tech ETF or a cheaper large-cap China internet name (size net zero delta ~0). Hold 6–12 months; unwind if cross-border fund flows turn positive for the group or if company guidance is cut.
• Volatility capture: Sell near-term straddles/strangles around quarterly events only if implied vol > realized vol + 8 vol points (sell size 0.5–1% NAV equivalent). Rationale: post-trim, heightened IV creates short-term premium harvesting opportunities for disciplined sellers; cap exposure and hedge with delta-neutral futures.
• Risk-off stop and liquidity rule: If BZ experiences a >20% gap down on macro/geopolitics or 5-day ADV doubles with no volume-fade, reduce exposure by 50% and re-evaluate. This protects against cascading ETF/quant-driven selling that is likely the dominant near-term downside vector.